Comunicati stampa e Novità

17.11.2008	mtm's CINtec Cytology Kit has higher specificity than HR-HPV testing improving the detection of cervical disease
13.11.2008	mtm laboratories AG to present at BIO-Europe 2008 in Mannheim/Heidelberg
17.09.2008	mtm laboratories launches CINtec^? Cytology kit in Europe with extended clinical claims for cervical cancer diagnosis
01.07.2008	mtm laboratories appoints Bob Silverman as CEO
17.04.2008	mtm laboratories today announced the signing for a third tranche of Euro 9.6 million to its Series C funding. This addition increases the total for the round to Euro 31.6 million (USD 50 million) in equity

05.02.2008	mtm laboratories launches Cervatec™ Assay for cervical cancer screening - New test significantly more sensitive in screening for cervical cancer than Pap Test
06.11.2007	The Clinical Utility of p16 as a Biomarker in Cervical Cancer Screening - Highlights from a satellite symposium held at EUROGIN 2007
01.11.2007	Hot pick of the month: mtm's p16 biomarker takes subjectivity out of cervical cancer screening
11.07.2007	mtm laboratories announces new pivotal trial data resulting in European launch of the CINtec® Histology kit with extended clinical claims
15.05.2007	Studies present compelling data on the p16^INK4a biomarker at the 16th International Congress of Cytology
04.01.2007	mtm laboratories opens subsidiaries in Italy, France and Spain to support the commercialization of its diagnostic products.
03.01.2007	mtm laboratories launches proprietary CINtec® Histology and CINtec® Cytology kits.
09.10.2006	mtm laboratories raises €22 million in Series C financing.
11.07.2006	mtm laboratories makes two senior clinical research appointments.
04.05.2006	Studies presented at EUROGIN highlight potential of p16^INK4a as biomarker for early detection and diagnosis of cervical cancer.
02.05.2006	mtm laboratories and Dako restructure license agreement regarding p16^INK4a CINtec® .
02.08.2005	mtm laboratories AG establishes US subsidiary, naming Robert Silverman President.
13.10.2004	mtm laboratories achieves ISO 9001 and ISO 13485 certification for design, manufacturing and distribution of In Vitro Diagnostics.
03.05.2004	mtm laboratories announces granting of US patent covering its CINtec® technology.
22.03.2004	mtm laboratories extends its supervisory board.
16.12.2003	Contribution to assessment of cervical cancer.

Stampare

Mappa del sito Contatto Marchio Termini generali e condizioni d'uso